Heparin Recall: Shenzhen Techdow Lot CU03232A
Announced 2026-10-28 · FDA
FDA is recalling Shenzhen Techdow Pharmaceutical Co., Ltd. Heparin Sodium Injection, USP 5,000 USP Units/mL, 1 mL multidose vials distributed by Hepalink USA. The recall is due to lack of assurance of sterility. A total of 251,000 vials (Lot CU03232A, Exp 1/31/2028) distributed nationwide in the USA are involved.
| Brand | Shenzhen Techdow Pharmaceutical Co., Ltd. |
|---|---|
| Product | Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01 |
| Reason | Lack of Assurance of Sterility |
| Severity | moderate |
| Units affected | 251000 |
| Distribution | Nationwide in the USA. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use any remaining vials from Lot CU03232A.
- Contact your healthcare provider or pharmacist for guidance and a replacement if appropriate.
- If you have the recalled product, follow disposal or return instructions provided by the supplier or FDA recall notice.
How to identify the recalled item
| Lot / date codes | Lot# CU03232A, Exp 1/31/2028 |
|---|---|
| Lot / date codes | Lot# CU03232A, Exp 1/31/2028 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.